Trial Profile
A phase II study of ISA101 [ISA HPV 01] monotherapy in patients with cervical cancer
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 29 May 2014
Price :
$35
*
At a glance
- Drugs ISA 101 (Primary)
- Indications Cervical cancer; Human papillomavirus infections
- Focus Adverse reactions; Pharmacodynamics
- 29 May 2014 New trial record